2022•Transplantation and Cellular TherapyOpen access
Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes
Malika A. Kapadia, Leslie Lehmann, Jeffery James Auletta, Lisa Beatty, Neel Sanjivbhai Bhatt, Robyn A. Blacken, Kathy Demmel, Therese Dodd, Catherine Desmond, Taylor Jennelle Fitch, Laura Flesch, David Hartley, John F. Huber, Hannah Ingraham, Rita M. Jakubowski, Anna Klunk, Christa Krupski, Katilyn Kusnier, Nicole Liberio, Joseph E. Maakaron, Mark A. Mueller, Kasiani C. Myers, Ahna L. H. Pai, Loretta Parker, Sagar S. Patel, Rachel Phelan, Veronika Polishchuk, Audrey M. Sigmund, Christine Sper, Sarah J. Tarquini, Mark Juckett, Samantha Mary Jaglowski, Christopher E. Dandoy, Seth Joshua Rotz
Open full text 16 citations
Abstract
Quality improvement and quality assurance form a complementary and independent relationship. Quality assurance measures compliance against industry standards using audits, whereas quality improvement is a continuous process focused on processes and systems that can improve care. The Model for Improvement is a robust quality improvement tool that transplant and cellular therapy teams can use to redesign healthcare processes. The Model for Improvement uses several components addressed in sequence to organize and critically evaluate improvement activities. Unlike other health sciences clinical research, quality improvement projects, and research are based on dynamic hypotheses that develop into observable, serial tests of change with continuous collection and feedback of performance data to stakeholders.